Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)
1 clinical trials · Condition
◉ Watch Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)
| Record | Firm | Date |
|---|---|---|
| A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors (NCT04799054) | Ascendis Pharma Oncology Division A/S | 2021-03-18 |
Track Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC) automatically
Every clearance here is in the API, with alerts when new ones post.